Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 397 results for "biocon"

Grasim Industries, Petronet LNG among 25 scrips that hit 52-week high
India Infoline

Gujarat Narmada Valley Fertilizers and Chemicals, KRBL among 1...

Alankit Limited, Bharat Bijlee Limited, Biocon Limited, Cholamandalam Investment and Finance Company Limited, Essel Propack Limited, Gujarat Narmada Valley Fertilizers and Chemicals Limited, Maithan Alloys Limited, Orient Paper & Industries Limited, ... India Infoline, 1 day ago
Livemint.com

Biocon Announces Insulin Glargine Biosimilar Has Met Key Phase III Milestones, Is On Track for US and EU Regulatory Filings

Goodwin
 JD Supra1 day ago Biocon's biosimilars progress  Economic Times1 week ago Biocon's profit increases 79.5% in March quarter  Livemint.com1 week ago Biocon logs Q4 revenue rise of 17% at Rs 1,004 cr  Deccan Herald1 week ago
[x]  
Livemint.com

Biocon challenges order in Delhi high court on breast cancer drug

until then, the drug makers would be free to market Trastuzumab as before New Delhi: The Delhi high court on Thursday allowed Biocon Ltd and its partner Mylan Pharmaceuticals Pvt. Ltd to continue marketing their breast cancer drug Trastuzumab until ...
 Livemint.com1 week ago Biocon, Mylan likely to appeal Delhi HC ruling on Roche's cancer drug trastuzumab  Economic Times1 week ago Biocon, Mylan to challenge Delhi HC interim order on breast cancer drug  Livemint.com1 week ago Delhi High Court order on copies of Roche's cancer drug draws flak  Economic Times1 week ago
[x]  
Deccan Chronicle

How Biocon's Kiran Mazumdar Shaw became the Mythbreaker

She was on her way to Inverness to become a brewmaster in the land of Scotch when life took an unexpected turn. But that was probably the last lucky accident in the gritty tale of Kiran Mazumdar Shaw. Once she took the new road, she clearly knew ...
 Deccan Chronicle1 week ago Kiran Mazumdar Shaw: Narayana Murthy is a role model  Deccan Chronicle1 week ago Standing her ground  Business Standard1 week ago Kiran Mazumder-Shaw: A journey marked by grit  Business Standard1 week ago
[x]  
India Infoline

Pharmaceutical Newsletter - April 25 to 29, 2016

Top News Delhi HC allows Biocon, Mylan to continue sale of Cancer drugs The Delhi High Court has allowed Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd to continue manufacturing and marketing their breast cancer drug under brand names CANMAb and ...
 India Infoline6 days ago BIOCON : Delhi High Court permits Biocon, Mylan to carry on trade of Cancer drugs  4 Traders1 week ago PTI - HC-DRUGS - HC allows Biocon, Mylan to continue manufacturing cancer drugs  Namibia Press Agency1 week ago Delhi HC allows Biocon, Mylan to continue sale of Cancer drugs  India Infoline1 week ago
[x]  

Biosimilar insulin Glargine to make $100 m from FY18: Biocon

Biocon RD team is working on the second phase of the development of oral insulin, and Kiran Mazumdar-Shaw, Chairman MD, Biocon, hopes that it becomes an approved product in the next 2-3 years.
 Money Control1 week ago Realisations from insulin biosimilar to start from FY17: Biocon  Money Control1 month ago Realisations from Glargine to start coming in from FY17: Biocon  Money Control1 month ago
India Infoline

5 mid-cap stocks to watch out for in derivatives

Traders in the derivatives market are betting on select mid-cap stocks for the May series such as M&M Financial, Biocon, Bata India, Titan Company and Havells India. These stocks have seen significant surge in both open interest and stock prices in ...
 Economic Times1 week ago Biocon, Havells India among 34 stocks that hit 52-week high  India Infoline4 weeks ago Wishy-Washy Wednesday...Sensex, Nifty shut lower again  India Infoline1 day ago Epic Research Daily Derivative Stock Market Report 3rd May 2016  Press Release Ping3 days ago
[x]  

Biocon: Near-term positives priced in

DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"
 Business Standard6 days ago

Biocon, Piramal & GSK buck the pharma trend, outperform amid absence of FDA issues

By Kiran Somvanshi ET INTELLIGENCE GROUP: Investors are essentially opportunists. At a time when USFDA has become a dreaded word for pharma stocks and most have lost fancy of the Street, few stocks have found favour with the investors. Biocon, ...
 Economic Times1 week ago
International Business Times India

Delhi High Court allows Indian biopharma companies to manufacture cheaper anti-cancer drugs

The Delhi High Court on Monday gave approval to Indian biopharma companies Biocon and Reliance Life Sciences for the manufacture and sale of breast cancer drug trastuzumab, which is originally made by the Swiss drug-maker Roche. The Delhi High ...
 International Business Times India1 week ago DELHI HC STRIKES DOWN BREAST CANCER BIOSIMILARS' APPROVAL FOR ROCHE DRUG  Pharmacy Choice1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less